Brief: Anthera announces expansion of screening in European sites in phase 3 result clinical study of sollpura
06/07/2017 13:30
July 6 (Reuters) - Anthera Pharmaceuticals Inc ANTH.O :
* Anthera announces expansion of screening in European sites
in phase 3 result clinical study of sollpura
* Anthera Pharmaceuticals Inc - international enrollment is
expected to provide topline data at end of 2017 or early 2018
Source text for Eikon: ID:nGNXNYUGNa
Further company coverage: ANTH.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Anthera Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Micron, Darden, Kroger, American Outdoor
Brief: Anthera Pharma's Board Approves Personnel Reorganization Plan
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, Netflix, BlueLinx, Micron
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, BlueLinx, Orexigen, Micron
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, Orexigen, Goldman